Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Name: Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
License: Public Domain

Eli Lilly and Company

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

carcinoma

carcinoma, non-small-cell lung

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 184860
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.